Skip to main content
Loading...
Menu social network
LinkedIn
Facebook
X
Youtube
Menu top
Assistance
User account menu
Log in
Main navigation
Home
Programme
Download the app
App
Download the app
App
Menu
Login
Close
Main navigation mobile
Home
Programme
Menu top
Assistance
Menu social network
LinkedIn
Facebook
X
Youtube
25 results
- D1.340 - Attack burden and patient-reported outcomes in adults with hereditary angioedema: associations with quality of life, pain, and coping strategies
- D1.337 - Long-Term Safety, Tolerability, and Effectiveness of Berotralstat in Hereditary Angioedema: Interim Analysis of the APeX-N Post-Authorization Study
- D1.339 - Renal and urinary tract disorders in inborn errors of immunity
- D1.341 - Severe Atopic Features with Prematurity and Ichthyosis: Ichthyosis Prematurity Syndrome
- D1.342 - Case Report: Off-Label Dosage of Berotralstat in Hereditary Angioedema
- D1.343 - Common Variable Immunodeficiency Associated Enteropathy: A Single-Center Experience
- D1.344 - Hidden Immunodeficiency in Adult Bronchiectasis: Lymphocyte Subsets, Humoral Defects, and Genetic Findings
- D1.346 - Clinically significant gastrointestinal endoscopic findings in asymptomatic patients with common variable immunodeficiency
- D1.347 - Lanadelumab in Children with Hereditary Angioedema Aged 2 to
D2.232 - Aquagenic Urticaria: High Atopic Comorbidity, Familial Aggregation, and Differential Water Reactivity
D2.233 - Epidemiology, Patient Characteristics, and Treatment Responses of Chronic Urticaria in Türkiye: A Systematic Literature Review
D2.237 - Patient-reported changes in urticaria activity after tattoo placement
D2.238 - Bilastine fast onset and strong peripheral antihistaminic activity: comparison with oral second-generation antihistamines and intramuscular dexchlorpheniramine in histamine-induced wheal and flare models
D2.239 - Oral and parenteral bilastine, fast onset and strong peripheral antihistaminic activity: comparison with oral second-generation antihistamines and intramuscular dexchlorpheniramine in wheal and flare models
D2.241 - Successful Slow Desensitization to Niraparib Following Failed Olaparib Desensitization in a Patient with Ovarian Cancer
D2.242 - Chronic Urticaria and Thyroid Disease: Analysis of Clinical, Laboratory Data and Therapeutic Response in the Mediterranean Area of Tarragona
D2.243 - Impact of simultaneous skin clearance and itch relief with lebrikizumab in patients with atopic dermatitis: post-hoc analysis from ADvocate1/2
D2.229 - Food Allergy in Ukrainian Children: Risk Factors, Early Allergen Introduction and Natural History
D2.234 - Mimicry of delayed pressure urticaria. Clinical case reports
D2.235 - Urticaria Voices: Patient-reported disease burden and treatment experiences in Chronic Spontaneous Urticaria in China - A real-world evidence study (UV in China)
Pagination
Current page
1
Page
2
Next page
Next
Last page
Last
Download the app
The congress at your fingertips
Available on
Download